Blue Square Asset Management, LLC Argenx Se Transaction History

Blue Square Asset Management, LLC

  • $185 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$269.58 - $378.88 $219,977 - $309,166
-816 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$254.45 - $351.06 $293,635 - $405,123
-1,154 Reduced 58.58%
816 $257,000
Q4 2021

Feb 09, 2022
BUY
$272.01 - $353.03 $535,859 - $695,469
1,970 New
1,970 $690,000

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Blue Square Asset Management, LLC Portfolio

Follow Blue Square Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Square Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email